Tesamorelin 10 mg is a stabilized GHRH analogue under investigation in growth-hormone axis research. Studied extensively in pituitary and IGF-1 research, with a long history of academic research in endocrinology.
Research Profile
- GHRH analogue (stabilized)
- Studied in GH/IGF-1 axis, pituitary, and visceral-adiposity research
- Well-characterized in academic literature
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: Tesamorelin
- Dosage: 10 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
